Diagnos Inc. (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 139 | 394 | 297 | 663 | 194 |
| Marketable Securities | 300 | 300 | 0 | N/A | 0 |
| Receivables | 107 | 243 | 243 | 368 | 330 |
| TOTAL | $636 | $1,043 | $575 | $1,106 | $602 |
| Non-Current Assets | |||||
| PPE Net | 319 | 222 | 248 | 190 | 204 |
| TOTAL | $319 | $222 | $248 | $190 | $204 |
| Total Assets | $955 | $1,264 | $823 | $1,296 | $806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 185 | 184 | 169 | 245 | 125 |
| Accounts payable and accrued liabilities | 332 | 305 | 288 | 299 | 391 |
| Accrued Expenses | 187 | 176 | 172 | 159 | 140 |
| TOTAL | $809 | $757 | $719 | $779 | $738 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,668 | 2,651 | 1,900 | 1,911 | 1,145 |
| Deferred Revenues | 22 | 9 | 7 | 12 | 17 |
| TOTAL | $2,898 | $2,784 | $2,052 | $2,036 | $1,277 |
| Total Liabilities | $3,707 | $3,541 | $2,771 | $2,815 | $2,016 |
| Shareholders' Equity | |||||
| Common Shares | 36,484 | 36,204 | 35,915 | 35,680 | 35,680 |
| Retained earnings | -49,028 | -48,279 | -47,526 | -46,744 | -46,230 |
| Other shareholders' equity | 9,792 | 9,798 | 9,664 | 9,545 | 9,341 |
| TOTAL | $-2,752 | $-2,277 | $-1,948 | $-1,519 | $-1,210 |
| Total Liabilities And Equity | $955 | $1,264 | $823 | $1,296 | $806 |